ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00914758
Recruitment Status : Unknown
Verified June 2009 by Washington Neuropsychology Research Group.
Recruitment status was:  Enrolling by invitation
First Posted : June 5, 2009
Last Update Posted : June 5, 2009
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by:
Washington Neuropsychology Research Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2011
  Estimated Study Completion Date : December 2011